Re: The problem...as I see it
in response to
by
posted on
Oct 16, 2020 01:43PM
I believe what we are talking about is Invokana, correct? (patients with type 2DM and CVD). Note FDA approval (underscored) below.
https://www.tctmd.com/news/diabetes-drug-canagliflozin-gets-mace-reduction-indication
Janssen. US FDA approves Invokana (canagliflozin) to reduce the risk of heart attack, stroke, or cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. Published on: October 30, 2018. Accessed on: November 1, 2018.
Koo